PMC:7377212 / 7396-7651 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T14","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"327","span":{"begin":134,"end":144},"obj":"Disease"},{"id":"328","span":{"begin":208,"end":216},"obj":"Disease"}],"attributes":[{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"MESH:D003920"},{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T109","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"T110","span":{"begin":59,"end":61},"obj":"Disease"},{"id":"T111","span":{"begin":138,"end":140},"obj":"Disease"},{"id":"T112","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":39,"end":40},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T61","span":{"begin":66,"end":67},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T65","span":{"begin":36,"end":38},"obj":"Chemical"},{"id":"T66","span":{"begin":52,"end":54},"obj":"Chemical"},{"id":"T67","span":{"begin":59,"end":61},"obj":"Chemical"},{"id":"T68","span":{"begin":103,"end":105},"obj":"Chemical"},{"id":"T69","span":{"begin":138,"end":140},"obj":"Chemical"},{"id":"T70","span":{"begin":166,"end":169},"obj":"Chemical"},{"id":"T71","span":{"begin":214,"end":227},"obj":"Chemical"}],"attributes":[{"id":"A65","pred":"chebi_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/CHEBI_73419"},{"id":"A66","pred":"chebi_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/CHEBI_73419"},{"id":"A67","pred":"chebi_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A68","pred":"chebi_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A69","pred":"chebi_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A70","pred":"chebi_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A71","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"}],"text":"mg·day−1 days 6–10 Typical COVID-19 ND A. fumigatus ND (-) TA PCR A. fumigatus, serum PCR (-), BDG (-) NR No host factor Putative only if TA considered equivalent to BAL None Alive\nParis, France [9] 63 F Diabetes, dexamethasone 20 mg·day−1 days 1–5, 10 mg"}